Financials
- Market Capitalization 210.12 M
- Employee 95
- Founded N/A
- CEO Daniel Vitt
- Website www.imux.com
- Headquarter Delaware, United States
- FIGI BBG001M75SX4
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.34
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3589 | CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 10.91 USD | -1.98% | +6.96% | +20.42% | -34.28% | 211.01 M USD | ||
| 3591 | ANTX AN2 Therapeutics, Inc. - Common Stock | 5.58 USD | -2.79% | -4.12% | +4.30% | +398.21% | 210.57 M USD | ||
| 3594 | ORMP Oramed Pharmaceuticals Inc. - Common Stock | 5.03 USD | -1.37% | +4.57% | +22.09% | +135.05% | 209.23 M USD | ||
| 3596 | IPHA Innate Pharma S.A. - American Depositary Shares | 2.23 USD | 0.00% | +0.90% | +29.65% | +7.21% | 208.99 M USD |